|
GB201008826D0
|
|
Production of metabolites
|
|
GB0806592D0
|
|
Conversion of stilbenoids
|
|
GB0806595D0
|
|
Recovery of stilbenoids
|
|
GB0806256D0
|
|
Production of stilbenoids
|
|
GB0800674D0
|
|
Production of consumable products
|
|
GB0725075D0
|
|
Metabolically engineered fungal cells with increased content of polyunsaturated fatty acids
|
|
GB0714671D0
|
|
Microbial bioreaction process
|
|
GB0614442D0
|
|
Metabolically engineered cells for the production of pinosylvin
|
|
WO2005118814A2
|
|
Metabolically engineered cells for the production of polyunsaturated fatty acids
|
|
GB0503657D0
|
|
Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof
|
|
US2005009135A1
|
|
Metabolically engineered micro-organisms having improved galactose uptake
|
|
GB0215173D0
|
|
Determining gene function
|
|
US7018829B1
|
|
Metabolically engineered microbial cell with an altered metabolite production
|
